Three-dimensional clusters of human neurons could allow scientists to watch neurological diseases develop in the lab.

Novartis researchers want to use the technology to help them design new drugs.

We leave the lab to find out what people know about cell and gene therapy.

A strong background in biological research prepared Daniel Rooks for his role in shaping the early clinical development of new medicines

Novartis team shares results of a massive oncology experiment with the world to accelerate drug discovery.

Discovery points toward treatment options beyond insulin injections

All treatments that exist today started with patients volunteering to participate in a study and healthcare professionals offering their expertise.

With external help from Novartis, an Argentinian researcher was able to begin his search for a new medicine for tuberculosis.

Novartis hopes to prevent, treat and block malaria and is conducting clinical trials to test some promising therapies. Learn more.

A new type of medicine that targets RNA was discovered by accident and could change the way some diseases are treated.